| Structure |
Chemical Name |
CAS |
MF |
 |
ADENYLYL(3'>5')CYTIDINE FREE ACID |
2382-66-3 |
C19H25N8O11P |
 |
CEFMETAZOLE MMT ISOMER |
|
|
 |
Cyclobutanecarboxylic acid, 3-(methylamino)-, 1-methylethyl ester, cis- |
2136718-64-2 |
C9H17NO2 |
 |
Vanadyl Riboside Complex (RVC/VRC) |
|
|
 |
Cefminox for system suitability |
|
|
 |
Flomoxef Intermediate NaMT |
|
|
 |
3,4-(Methylenedioxy)aniline |
14268-66-7 |
C7H7NO2 |
 |
Methenolone enanthate |
303-42-4 |
C27H42O3 |
 |
8-OXO-DG |
|
|
![4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid](/CAS/GIF/641569-94-0.gif) |
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid |
641569-94-0 |
C17H14N4O2 |
 |
4-Bromopyrazole |
2075-45-8 |
C3H3BrN2 |
 |
Fmoc-GIn(Trt)-Aib-OH |
|
|
 |
tert-Butyl ((1r,4r)-4-((E)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)cyclohexyl)carbamate |
3057863-74-5 |
C19H34BNO4 |
 |
Methyl (R)-4,4-difluoropyrrolidine-2-carboxylate hydrochloride |
1408057-39-5 |
C6H10ClF2NO2 |
![(1S,2R,3S,5R)-2-(Benzyloxymethyl)-6-oxabicyclo[3.1.0]hexan-3-ol](/CAS/GIF/117641-39-1.gif) |
(1S,2R,3S,5R)-2-(Benzyloxymethyl)-6-oxabicyclo[3.1.0]hexan-3-ol |
117641-39-1 |
C13H16O3 |
![(6β)-3-(1-Methyl-1H-tetrazole-5-ylthiomethyl)-7α-amino-7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]octa-2-ene-2-carboxylic acid benzhydryl ester](/CAS/GIF/66510-99-4.gif) |
(6β)-3-(1-Methyl-1H-tetrazole-5-ylthiomethyl)-7α-amino-7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]octa-2-ene-2-carboxylic acid benzhydryl ester |
66510-99-4 |
C24H24N6O5S |
 |
tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate |
571188-59-5 |
C14H22N4O2 |
 |
N2-Isobutyryl-2'-Fluoro-2'-deoxyguanosine |
80681-25-0 |
C14H18FN5O5 |
 |
7-DEAZA-2'-DEOXYINOSINE |
97224-58-3 |
C11H13N3O4 |
 |
5-Methyl-3-phenylisoxazole-4-carbonyl chloride |
16883-16-2 |
C11H8ClNO2 |
 |
N-ForMyl- |
104872-27-7 |
C29H53NO5 |
![3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine](/CAS/GIF/1022150-12-4.gif) |
3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine |
1022150-12-4 |
C22H22N6O |
 |
4-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline |
190728-25-7 |
C17H16N2O3 |
 |
ETHYL 3-BUTENOATE |
1617-18-1 |
C6H10O2 |
 |
Secondary Prostaglandin Metabolite LC-MS Mixture |
|
|
 |
Indoline |
496-15-1 |
C8H9N |
 |
3-CYANOCOUMARIN |
15119-34-3 |
C10H5NO2 |
 |
N-(3-Fluoro-4-methyl-8-oxo-5,6,7,8-tetrahydro-1-naphthyl)acetamide |
143655-58-7 |
C13H14FNO2 |
 |
((1R,3R)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S,E)-5,6-dimethyl-6-(trimethylsilyloxy)hept-3-en-2-yl)-7a-methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)cyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldimethylsilane) |
2186604-89-5 |
C42H80O3Si3 |
 |
Anti-Cyclooxygenase 3/Cox3 |
|
|
 |
Ceftazidime and Avibactam Sodium for Injection |
|
|
 |
13,14-DIHYDRO-15-KETO PROSTAGLANDIN D2 |
59894-07-4 |
C20H32O5 |
 |
9ALPHA,15S-DIHYDROXY-11-OXO-PROST-13E-EN-1-OIC ACID |
17968-82-0 |
C20H34O5 |
 |
2-Cyanoethyl 3-oxobutanoate |
65193-87-5 |
C7H9NO3 |
![Carbamic acid, N-[(14S,18S)-18,19,20,21-tetrahydro-25,25-dimethyl-15,22-dioxo-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-17H-5,3-([4,2]-endo-thiazolopropano[1,3]-endo-pyridazinomethanoxypropano)-1H-indol-14-yl]-, 1,1-dimethylethyl ester](/CAS/20240320/GIF/2764998-33-4.gif) |
Carbamic acid, N-[(14S,18S)-18,19,20,21-tetrahydro-25,25-dimethyl-15,22-dioxo-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-17H-5,3-([4,2]-endo-thiazolopropano[1,3]-endo-pyridazinomethanoxypropano)-1H-indol-14-yl]-, 1,1-dimethylethyl ester |
2764998-33-4 |
C35H48BN5O7S |
![5,6,7,7a-Tetrahydrothieno[3,2-c]pyridine-2(4H)-one hydrochloride](/CAS/GIF/115473-15-9.gif) |
5,6,7,7a-Tetrahydrothieno[3,2-c]pyridine-2(4H)-one hydrochloride |
115473-15-9 |
C7H10ClNOS |
 |
Cefcanel |
41952-52-7 |
C19H18N4O5S3 |
 |
Eseroline |
469-22-7 |
C13H18N2O |
 |
3,4-Diiodopyrazole |
6645-70-1 |
C3H2I2N2 |
 |
Fendizoic acid |
84627-04-3 |
C20H14O4 |
 |
Lysergamide, 1-acetyl-N,N-diethyl- (6CI,7CI) |
3270-02-8 |
C22H27N3O2 |
 |
4-(4-Chloro-phenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid ethyl ester |
5948-71-0 |
C14H15ClN2O3 |
 |
DIMETHYL-(3-(TRIFLUOROMETHYL)-PHENYL)-MALONATE |
138485-29-7 |
C12H11F3O4 |
![BenzaMide, 2-[(3-iodo-1H-indazol-6-yl)thio]-N-Methyl-](/CAS/GIF/885126-34-1.gif) |
BenzaMide, 2-[(3-iodo-1H-indazol-6-yl)thio]-N-Methyl- |
885126-34-1 |
C15H12IN3OS |
 |
ForMoterol-IMpurity-B |
1224588-66-2 |
C18H22N2O4 |
![N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine](/CAS/GIF/477600-73-0.gif) |
N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
477600-73-0 |
C20H25N5 |
 |
(1R,3aR,7aR)-1-((R)-6-hydroxy-6-Methylheptan-2-yl)-7a-Methylhexahydro-1H-inden-4(2H)-one |
70550-73-1 |
C18H32O2 |
![3-(1,1-diMethylethyl)-7a-ethenyltetrahydro-1-hydroxy-(3R,7aR)-3H,5H-Pyrrolo[1,2-c]oxazol-5-one](/CAS/GIF/1214741-21-5.gif) |
3-(1,1-diMethylethyl)-7a-ethenyltetrahydro-1-hydroxy-(3R,7aR)-3H,5H-Pyrrolo[1,2-c]oxazol-5-one |
1214741-21-5 |
C12H19NO3 |
 |
ethyl 7-chloro-8-cyano-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate |
117528-64-0 |
C16H12ClFN2O3 |
 |
(S)-1-(2-(1-aMino-2-Methylpropan-2-ylaMino)acetyl)pyrrolidine-2-carbonitrile dihydrochloride (AMino pyrrolidine) |
739364-93-3 |
C11H22Cl2N4O |
![5-Chloropyrazolo[1,5-a]pyriMidine-3-carbonitrile](/CAS/20150408/GIF/1224288-92-9.gif) |
5-Chloropyrazolo[1,5-a]pyriMidine-3-carbonitrile |
1224288-92-9 |
C7H3ClN4 |
 |
AMinopentaMide Sulfate |
20701-77-3 |
C19H24N2O.H2O4S |
 |
(Ac)Phe-Lys(Alloc)-PABC-PNP |
|
C??H??N?O?? |
 |
2-(DiMethylaMino)acetaldehyde sulfite |
1413945-87-5 |
C4H11NO4S |
 |
(R)-ethyl thiazolidine-4-carboxylate |
|
C6H11NO2S |
 |
Ranolazine-d3 |
1054624-77-9 |
C24H33N3O4 |
 |
5-Benzylidenehydantoin |
3775-01-7 |
C10H8N2O2 |
![5-(4-{2-[5-(tert-Butyl-dimethyl-silanyloxy)-2-methylene-cyclohexylidene]-ethylidene}-7a-methyl-octahydro-inden-1-yl)-hexanoic acid ethyl ester](/CAS/GIF/147125-14-2.gif) |
5-(4-{2-[5-(tert-Butyl-dimethyl-silanyloxy)-2-methylene-cyclohexylidene]-ethylidene}-7a-methyl-octahydro-inden-1-yl)-hexanoic acid ethyl ester |
147125-14-2 |
C33H56O3Si |
 |
Clopidogrel camphorsulfonate |
120202-68-8 |
C26H32ClNO6S2 |
![(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity)](/CAS/GIF/130793-28-1.gif) |
(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity) |
130793-28-1 |
C29H55NO6 |
 |
1-Phenyl-3-(2-hydroxyethyl)thiourea |
102-12-5 |
C9H12N2OS |
 |
McMMAE |
863971-24-8 |
C49H78N6O10 |
 |
2-Amino-4-bromo-3-fluorobenzoic acid |
1416013-62-1 |
C7H5BrFNO2 |
 |
AMoxicillin TriMer |
174391-69-6 |
C48H57N9O15S3 |
 |
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)Methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)Methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
1246391-73-0 |
C37H42F2N8O4 |
 |
Neratinib Maleate |
915942-22-2 |
C34H33ClN6O7 |
 |
Oclacitinib Maleate(PF-03394197) |
1208319-27-0 |
C19H27N5O6S |
 |
Meropenem IMP A |
1053703-36-8 |
C17H27N3O6S |
 |
4,6,7-trihydroxycoumarin |
22649-24-7 |
C9H6O5 |
 |
Velpatasvir intermediate |
1378391-42-4 |
C31H34BrNO8 |
 |
Methyl 4-isopropyl-3,5-dimethoxybenzoate |
344396-17-4 |
C13H18O4 |
![(2S)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)-1-Pyrrolidinecarboxylic acid phenylmethyl ester](/CAS/20180703/GIF/1420478-88-1.gif) |
(2S)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)-1-Pyrrolidinecarboxylic acid phenylmethyl ester |
1420478-88-1 |
C18H18BrN5O2 |
 |
(9H-fluoren-9-yl)methyl (4-(dimethoxymethyl)phenyl)carbamate |
475160-88-4 |
C24H23NO4 |
 |
Posaconazole Impurity 18 |
213381-06-7 |
C37H42F2N8O4 |
 |
2-bromo-N-(4,5-dimethylisoxazol-3-yl)-N-(methoxymethyl)benzenesulfonamide |
415697-57-3 |
C13H15BrN2O4S |
![2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile](/CAS/20180531/GIF/1187594-13-3.gif) |
2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile |
1187594-13-3 |
C22H31N7O3SSi |
 |
Eribulin intermediate |
253128-15-3 |
C40H58O12 |
 |
tert-butyl 2-(azetidin-3-yl)acetate hydrochloride |
2173991-98-3 |
C9H18ClNO2 |
 |
Δ3-Flomoxef sodium |
|
|
 |
Derivatives intermediate 3 |
1213710-50-9 |
C21H30N2O |
 |
Lixivaptan intermediate-V |
168079-19-4 |
C19H16ClN3O |
 |
5-(Acetamido)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide |
31127-80-7 |
C16H20I3N3O7 |
 |
(+)-beta-Pinene oxide |
6931-54-0 |
C10H16O |
 |
Ethyl 2-(2-aminothiazole-4-yl)-2-hydroxyiminoacetate |
64485-82-1 |
C7H9N3O3S |
 |
1H-Tetrazole-1-acetic acid |
21732-17-2 |
C3H4N4O2 |
 |
3-Bromo-5-fluoroanisole |
29578-39-0 |
C7H6BrFO |
 |
Allopregnanolone |
516-54-1 |
C21H34O2 |
 |
4-Methylimidazole |
822-36-6 |
C4H6N2 |
 |
9-OXO-11ALPHA-15S-DIHYDROXY-PROSTA-5Z,13E-DIEN-1-OIC-3,3,4,4-D4 ACID |
34210-10-1 |
C20H28D4O5 |
 |
5-(4-Hydroxyphenyl)-2,4-imidazolidinedione |
2420-17-9 |
C9H8N2O3 |
 |
2-Azepan-1-yl-ethylamine |
51388-00-2 |
C8H18N2 |
 |
4,7-DIHYDROXYCOUMARIN |
1983-81-9 |
C9H6O4 |
 |
Fmoc-Gly-Gly-Phe-Gly-CH2-O-CH2-Cbz |
2264011-97-2 |
C40H41N5O9 |
 |
(9H-fluoren-9-yl)methyl (S)-(1-(methylamino)-1-oxo-5-ureidopentan-2-yl)carbamate |
|
|
 |
(9H-fluoren-9-yl)methyl (S)-(4-methyl-1-(methylamino)-1-oxopentan-2-yl)carbamate |
|
|
 |
(1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline |
118864-75-8 |
C15H15N |
 |
(2S,3R)-2-amino-3-methylpent-4-enamide |
2209873-96-9 |
C6H12N2O |
![4alpha,5-epoxy-5alpha-androst-2-eno[2,3-d]isoxazol-17beta-ol](/CAS/20180808/GIF/20051-76-7.gif) |
4alpha,5-epoxy-5alpha-androst-2-eno[2,3-d]isoxazol-17beta-ol |
20051-76-7 |
C20H27NO3 |
 |
Carbamazepine intermediate |
|
|
 |
(6R,7S)-Ceftriaxone Epimer |
|
|